AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
NCT05195645
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Myocarditis
Interventions
DRUG:
Abatacept 250 MG
Sponsor
Assistance Publique - Hôpitaux de Paris